-
Sector Analysis
The Open Championship 2023 – Post Event Analysis
The Open Championship 2023 Analysis Report Overview There were 32 broadcast deals struck for media rights to show The Open 2023 across the world. This year’s Open had 13 brands partnering for the tournament. The Open has lucrative broadcast deals across the globe, with NBC ESPN, RDS, and TSN covering many regions across the Americas. The Open Championship 2023 analysis report provides a detailed overview of the key facts and events which took place in the UK. The report identifies...
-
Sector Analysis
US Open (Golf) 2023 – Event Analysis
US Open (Golf) 2023 Analysis Report Overview Around 32 broadcast deals were struck for media rights to air the 2023 US Open across the globe. The tournament has lucrative broadcast deals around the world, especially with American network NBC. Furthermore, 7 brands partnered with the US Open for the 2023 competition. The US Open (Golf) 2023 analysis report provides a detailed overview of the key facts and events which took place across the five games of the series. The report...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Nebivolol in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Nebivolol in Open-Angle Glaucoma Drug Details:Nebivolol is under development for the treatment of primary open angle...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Bimatoprost in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Bimatoprost in Open-Angle Glaucoma Drug Details:Bimatoprost (T-4032) is under development for the treatment of open-angle glaucoma...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Timolol in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Timolol in Open-Angle Glaucoma Drug Details:Timolol is under development for the treatment of primary open angle...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Travoprost in Open-Angle Glaucoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Travoprost in Open-Angle Glaucoma Drug Details: Travoprost is under development for the treatment of elevated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sepetaprost in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Sepetaprost in Open-Angle Glaucoma Drug Details:Sepetaprost (DE-126) is under development for the treatment of ocular hypertension...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Bimatoprost Grenod in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Bimatoprost Grenod in Open-Angle GlaucomaDrug Details: Bimatoprost grenod (NCX-470) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PER-001 in Open-Angle Glaucoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PER-001 in Open-Angle Glaucoma Drug Details: PER-001 is under development for the treatment of open-angle...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TO-O-1001 in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TO-O-1001 in Open-Angle GlaucomaDrug Details:TO-O-1001 is under development for the treatment of open-angle glaucoma and ocular...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VVN-539 in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VVN-539 in Open-Angle Glaucoma Drug Details: VVN-539 is under development for the treatment of open angle...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ONL-1204 in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ONL-1204 in Open-Angle Glaucoma Drug Details:ONL-1204 is under development for the treatment of retinal detachment, retinitis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QLS-101 in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.QLS-101 in Open-Angle Glaucoma Drug Details:QLS-101 is under development for the treatment of ocular hypertension, normal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TJO-002 in Open-Angle Glaucoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TJO-002 in Open-Angle Glaucoma Drug Details:TJO-002 is under development for the treatment of open-angle glaucoma and...
-
Product Insights
New![]()
